{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:20:32Z","timestamp":1793769632216,"version":"4.6.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UCSF Give Breast Cancer the Boot"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study characterizes attitudes and decision-making around the desire for future children in young women newly diagnosed with early-stage breast cancer and assesses how clinical factors and perceived risk may impact these attitudes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective study in women\u2009&lt;\u200945\u00a0years with newly diagnosed stage 1\u20133 breast cancer. Patients completed a REDCap survey on fertility and family-building in the setting of hypothetical risk scenarios. Patient, tumor, and treatment characteristics were collected through surveys and medical record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 140 study patients [median age\u2009=\u200941.4 (range 23\u201345)], 71 (50.7%) were interested in having children. Women interested in future childbearing were younger than those who were not interested (mean\u2009=\u200935.2 [\n                      <jats:italic>SD<\/jats:italic>\n                      \u2009=\u20095.2] vs 40.9\u00a0years [3.90], respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and more likely to be childless (81% vs 31%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). 54 women (77.1% of patients interested in future children) underwent\/planned to undergo oocyte\/embryo cryopreservation before chemotherapy. Interest in future childbearing decreased with increasing hypothetical recurrence risk, however 17% of patients wanted to have children despite a 75\u2013100% hypothetical recurrence risk. 24.3% of patients wanted to conceive\u2009&lt;\u20092\u00a0years from diagnosis, and 35% of patients with hormone receptor positive tumors were not willing to complete 5\u00a0years of hormone therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Many young women diagnosed with early-stage breast cancer prioritize childbearing. Interest in having a biologic child was not associated with standard prognostic risk factors. Interest decreased with increasing hypothetical recurrence risk, though some patients remained committed to future childbearing despite near certain hypothetical risk. Individual risk assessment should be included in family-planning discussions throughout the continuum of care as it can influence decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-023-07206-5","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T07:02:07Z","timestamp":1704783727000},"page":"509-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer"],"prefix":"10.1007","volume":"204","author":[{"given":"Saumya","family":"Umashankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylee","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Majure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Huppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Melisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2978-6249","authenticated-orcid":false,"given":"A. Jo","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"7206_CR1","unstructured":"SEER*Explorer: an interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Accessed 2 Jun 2023 Data source(s): SEER Incidence Data, November 2022 Submission (1975\u20132020), SEER 22 registries"},{"issue":"5","key":"7206_CR2","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718\u20131729. https:\/\/doi.org\/10.1200\/JCO.1996.14.5.1718","journal-title":"J Clin Oncol"},{"issue":"5","key":"7206_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12282-017-0764-1","volume":"24","author":"C Koga","year":"2017","unstructured":"Koga C, Akiyoshi S, Ishida M, Nakamura Y, Ohno S, Tokunaga E (2017) Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer 24(5):714\u2013719. https:\/\/doi.org\/10.1007\/s12282-017-0764-1","journal-title":"Breast Cancer"},{"issue":"20","key":"7206_CR4","doi-asserted-by":"publisher","first-page":"e10634","DOI":"10.1097\/MD.0000000000010634","volume":"97","author":"Y Chen","year":"2018","unstructured":"Chen Y, Shi XE, Tian JH, Yang XJ, Wang YF, Yang KH (2018) Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: a meta-analysis. Medicine (Baltimore) 97(20):e10634. https:\/\/doi.org\/10.1097\/MD.0000000000010634","journal-title":"Medicine (Baltimore)"},{"issue":"24","key":"7206_CR5","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1200\/JCO.2006.06.9823","volume":"24","author":"K Oktay","year":"2006","unstructured":"Oktay K, Oktem O, Reh A, Vahdat L (2006) Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 24(24):4044\u20134046. https:\/\/doi.org\/10.1200\/JCO.2006.06.9823","journal-title":"J Clin Oncol"},{"issue":"9869","key":"7206_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805\u2013816. https:\/\/doi.org\/10.1016\/S0140-6736(12)61963-1","journal-title":"Lancet"},{"issue":"1","key":"7206_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10549-015-3511-3","volume":"153","author":"AJ Chien","year":"2015","unstructured":"Chien AJ, Duralde E, Hwang R et al (2015) Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Breast Cancer Res Treat 153(1):173\u2013181. https:\/\/doi.org\/10.1007\/s10549-015-3511-3","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7206_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.breast.2004.08.007","volume":"13","author":"L Barthelmes","year":"2004","unstructured":"Barthelmes L, Gateley CA (2004) Tamoxifen and pregnancy. Breast 13(6):446\u2013451. https:\/\/doi.org\/10.1016\/j.breast.2004.08.007","journal-title":"Breast"},{"issue":"16","key":"7206_CR9","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/cncr.33596","volume":"127","author":"T Sella","year":"2021","unstructured":"Sella T, Poorvu PD, Ruddy KJ et al (2021) Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer 127(16):2888\u20132894. https:\/\/doi.org\/10.1002\/cncr.33596","journal-title":"Cancer"},{"key":"7206_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv202","author":"NC Llarena","year":"2015","unstructured":"Llarena NC, Estevez SL, Tucker SL, Jeruss JS (2015) Impact of fertility concerns on tamoxifen initiation and persistence. J Natl Cancer Inst https:\/\/doi.org\/10.1093\/jnci\/djv202","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"7206_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/cncr.32546","volume":"126","author":"JM Letourneau","year":"2020","unstructured":"Letourneau JM, Wald K, Sinha N et al (2020) Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer 126(3):487\u2013495. https:\/\/doi.org\/10.1002\/cncr.32546","journal-title":"Cancer"},{"issue":"20","key":"7206_CR12","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","volume":"22","author":"AH Partridge","year":"2004","unstructured":"Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22(20):4174\u20134183. https:\/\/doi.org\/10.1200\/JCO.2004.01.159","journal-title":"J Clin Oncol"},{"issue":"22","key":"7206_CR13","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1200\/JCO.2005.07.773","volume":"23","author":"B Thewes","year":"2005","unstructured":"Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23(22):5155\u20135165. https:\/\/doi.org\/10.1200\/JCO.2005.07.773","journal-title":"J Clin Oncol"},{"issue":"11","key":"7206_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2013.52.8877","volume":"32","author":"KJ Ruddy","year":"2014","unstructured":"Ruddy KJ, Gelber SI, Tamimi RM et al (2014) Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol 32(11):1151\u20131156. https:\/\/doi.org\/10.1200\/JCO.2013.52.8877","journal-title":"J Clin Oncol"},{"issue":"3","key":"7206_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.fertnstert.2011.12.008","volume":"97","author":"J Kim","year":"2012","unstructured":"Kim J, Oktay K, Gracia C, Lee S, Morse C, Mersereau JE (2012) Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril 97(3):671\u2013676. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.12.008","journal-title":"Fertil Steril"},{"key":"7206_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB (2002) Statistical analysis with missing data, 2nd edn. Wiley, Princeton. https:\/\/doi.org\/10.1002\/9781119013563","edition":"2"},{"issue":"Suppl 1","key":"7206_CR17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.3747\/co.22.2338","volume":"22","author":"J Raphael","year":"2015","unstructured":"Raphael J, Trudeau ME, Chan K (2015) Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol 22(Suppl 1):S8\u2013S18. https:\/\/doi.org\/10.3747\/co.22.2338","journal-title":"Curr Oncol"},{"issue":"2","key":"7206_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.fertnstert.2017.10.029","volume":"109","author":"MB Moravek","year":"2018","unstructured":"Moravek MB, Confino R, Smith KN et al (2018) Long-term outcomes in cancer patients who did or did not pursue fertility preservation. Fertil Steril 109(2):349\u2013355. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.10.029","journal-title":"Fertil Steril"},{"issue":"1","key":"7206_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-020-05598-2","volume":"181","author":"IJH Vriens","year":"2020","unstructured":"Vriens IJH, Ter Welle-Butalid EM, de Boer M et al (2020) Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience. Breast Cancer Res Treat 181(1):77\u201386. https:\/\/doi.org\/10.1007\/s10549-020-05598-2","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7206_CR20","doi-asserted-by":"publisher","first-page":"e000459","DOI":"10.1136\/esmoopen-2018-000459","volume":"4","author":"A Kitano","year":"2019","unstructured":"Kitano A, Shimizu C, Yamauchi H et al (2019) Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists. ESMO Open 4(2):e000459. https:\/\/doi.org\/10.1136\/esmoopen-2018-000459","journal-title":"ESMO Open"},{"key":"7206_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.breast.2021.07.021","volume":"59","author":"AH Partridge","year":"2021","unstructured":"Partridge AH, Niman SM, Ruggeri M et al (2021) Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast 59:327\u2013338. https:\/\/doi.org\/10.1016\/j.breast.2021.07.021","journal-title":"Breast"},{"issue":"7","key":"7206_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1200\/JCO.22.01064","volume":"41","author":"O Pagani","year":"2023","unstructured":"Pagani O, Walley BA et al (2023) Adjuvant exemestane with ovarian suppression in premenopausal breast cancer: long-term follow-up of the Combined TEXT and SOFT trials. J Clin Oncol 41(7):1376\u20131382. https:\/\/doi.org\/10.1200\/JCO.22.01064","journal-title":"J Clin Oncol"},{"issue":"18","key":"7206_CR23","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","volume":"388","author":"AH Partridge","year":"2023","unstructured":"Partridge AH, Niman SM, Ruggeri M et al (2023) Interrupting endocrine therapy to attempt pregnancy after breast cancer. N Engl J Med 388(18):1645\u20131656. https:\/\/doi.org\/10.1056\/NEJMoa2212856","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07206-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T15:21:41Z","timestamp":1711120901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07206-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7206"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07206-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3189568\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of California (Protocol Number 177538, initial approval December 14, 2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of de-identified data as part of the research data set.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}